logo

Exact Sciences Corp. (EXAS)



Trade EXAS now with
  Date
  Headline
3/6/2018 6:01:23 AM Mayo Clinic's Paul Limburg To Join Exact Sciences Medical Leadership
1/11/2018 9:54:05 PM Exact Sciences Announces Upsize And Pricing Of $600 Mln Of 1.0% Convertible Senior Notes Due 2025
1/11/2018 4:05:05 PM Exact Sciences Announces Offering Of $500 Mln Convertible Senior Notes Due 2025
5/31/2017 9:12:23 AM Canaccord Is Increasing EXACT Sciences Corp. (EXAS) 2019 Estimate To 0.01 From -0.02
5/31/2017 9:11:34 AM Canaccord Is Raising EXACT Sciences Corp. (EXAS) 2018 Estimate To -0.94 From -0.97
5/31/2017 9:11:05 AM Canaccord Is Increasing EXACT Sciences Corp. (EXAS) 2017 Estimate To -1.41 From -1.42
5/31/2017 9:09:41 AM Canaccord Is Raising EXACT Sciences Corp. (EXAS) 2019 Rev. Estimate To 500 M From 495 M
5/31/2017 9:09:19 AM Canaccord Is Increasing EXACT Sciences Corp. (EXAS) 2018 Rev. Estimate To 330.0 M From 325.0 M
5/31/2017 9:08:51 AM Canaccord Is Raising EXACT Sciences Corp. (EXAS) 2017 Rev. Estimate To 205.0 M From 203.0 M
2/22/2017 9:21:44 AM Canaccord Is Raising EXACT Sciences Corp. (EXAS) 2018 Rev. Estimate To 264.2 M From 255.0 M
2/22/2017 9:21:30 AM Canaccord Is Increasing EXACT Sciences Corp. (EXAS) 2017 Rev. Estimate To 171.0 M From 158.0 M
2/22/2017 9:21:07 AM Canaccord Is Cutting EXACT Sciences Corp. (EXAS) 2018 Estimate To -1.21 From -0.96
2/22/2017 9:20:49 AM Canaccord Is Lowering EXACT Sciences Corp. (EXAS) 2017 Estimate To -1.52 From -1.45
2/22/2017 9:20:15 AM Canaccord Reiterates EXACT Sciences Corp. (EXAS) At Buy With $27 Up From $24 Price Target
1/9/2017 10:51:31 AM Canaccord Reiterates EXACT Sciences Corp. (EXAS) At Buy With $24 Price Target